A recent report from a federal watchdog reveals that Medicare Advantage plans received approximately $4.2 billion for dubious home diagnoses. UnitedHealth emerged as the top insurer linked to these questionable payments, with overall flagged payments amounting to $7.5 billion. The findings raise concerns about the integrity of home visits and the accuracy of the diagnoses used to justify these payments.